Advertisement Ciba implements Sopheon's Accolade process management system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Ciba implements Sopheon’s Accolade process management system

Accolade is expected to improve product-development efficiency and quality of execution

Sopheon has announced that Ciba, a manufacturer of specialty chemicals, has implemented the company’s Accolade product portfolio and innovation process management system to support its global initiative aimed at improving innovation governance and increasing profits and revenues from new products.

According to Sopheon, Accolade has been made available to more than 900 individuals on cross-functional teams responsible for product development at Ciba locations throughout Europe, Asia and the US.

Sopheon said that Accolade will serve as the key software component for Ciba’s management of its innovation system. The software’s governing capabilities are expected to improve product-development efficiency and quality of execution by prompting users to follow prescribed process steps and address the right business and technical questions at the right times to optimise the chances of success for projects in the pipeline.

Project management will be enhanced by increased transparency as Accolade system managers are able to not only retrieve instant updates on the status of individual projects but to access consolidated views that allow them to assess the cost, value and priority of projects comprising entire portfolios, added Sopheon.

Martin Riediker, chief innovation officer of Ciba, said: The solution has provided us with a state-of-the-art innovation management system. For the first time, we are able to monitor all aspects of our R&D initiatives and make truly well-informed decisions about which ones to support. As a result, we are in a position to significantly reduce the number of active projects in our development pipeline, and to back the most promising opportunities with more resources.